IPO registrations (S-1, F-1) · Registrants
DRUGABUSE SCIENCES INC
- SEC CIK
- 1104180 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-02-03, last 2000-10-11; 1 initial registration, 9 amendments
- Outcome
- Withdrawal requested 2000-10-13
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Business address
- 1430 OBRIEN DR, STE E, Menlo Park, CA 94025
- EIN
- 94-3222724
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $8.00–$9.00 per share (S-1/A filed 2000-10-11)
- Shares offered
- 4,000,000
- Listing
- Nasdaq under the symbol DASI
- Lead underwriters
- ABN AMRO; PaineWebber; UBS
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-02-03 | S-1 | S-1 (registration) | DRUGABUSE SCIENCES INC | 0000912057-00-003582 ↗ |
| 2000-02-17 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-007551 ↗ |
| 2000-03-07 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-010173 ↗ |
| 2000-03-28 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-014055 ↗ |
| 2000-04-03 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-015773 ↗ |
| 2000-04-05 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-016161 ↗ |
| 2000-08-23 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-038867 ↗ |
| 2000-09-15 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-041517 ↗ |
| 2000-10-06 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-043973 ↗ |
| 2000-10-11 | S-1/A | S-1/A (amendment) | DRUGABUSE SCIENCES INC | 0000912057-00-044360 ↗ |
| 2000-10-13 | RW | RW (withdrawal request) | DRUGABUSE SCIENCES INC | 0000912057-00-044752 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-10-11 | S-1/A | registration statement | $8.00–$9.00 | $8.50 | 4,000,000 | $34,000,000 | Nasdaq DASI | 3 | primary document; range, price sentence, shares headline, proceeds computed | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), CA first:
- SANGAMO THERAPEUTICS, INC CA
- GENITOPE CORP CA
- ABGENIX INC CA
- COLLATERAL THERAPEUTICS INC CA
- Life Technologies Corp CA
- STRATAGENE CORP CA
- Cordex Pharma, Inc. CA
- COTHERIX INC CA
- Cardiff Oncology, Inc. CA
- Eiger BioPharmaceuticals, Inc. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health